Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530111 · ClinicalTrials.gov registry record
Establishment of the 2H-labeling Protocol at Pennington Biomedical Research Center
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT03530111 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 11 participants.
The verdict
NCT03530111 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
A method has been developed to measure in vivo adipose kinetics and turnover rates, which is a substantive departure from previous indirect and in vitro approaches. This technique involves drinking deuterium (2H)-labeled water, with an initial ramp-up to increase body water 2H enrichment, followed by daily intake to maintain enrichment values. The 2H from the heavy water is incorporated into the DNA of the dividing cells, as well as the lipid component, providing measures of cell formation, lipid synthesis, and adipose turnover. The objective of the proposed study is to enroll women who are overweight (sedentary or physically active) in order to collect 2H-enriched adipose tissue specimens that will be utilized to establish this innovative 2H-labeling protocol at Pennington Biomedical Research Center. This study will also assess adipose kinetics in individuals with different levels of physical activity to better understand the association between in vivo adipose cell kinetics, physical activity, and metabolic health in humans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2020-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03530111
The ClinicalTrials.gov registry entry for NCT03530111 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03530111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03530111 about?
NCT03530111 is a clinical study titled "Establishment of the 2H-labeling Protocol at Pennington Biomedical Research Center". A method has been developed to measure in vivo adipose kinetics and turnover rates, which is a substantive departure from previous indirect and in vitro approaches. This technique involves drinking deuterium (2H)-labeled water, with an initial ramp-up to increase body water 2H enrichment, followed b...
What is the current status of trial NCT03530111?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2018-06-20. Estimated completion is 2020-02-28.
Who is sponsoring clinical trial NCT03530111?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.